BSEInsider Trading / SAST13 Aug 2026 · 13 Aug 2026, 03:50 pm
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Metz Advisory LLP & PACs
Metropolis Healthcare Ltd · 542650
✦ AI SummaryPledge
Metropolis Healthcare Ltd's promoter group has sold 10,50,000 shares through open market sale on August 11, 2026, representing 0.51% of the company's shareholding.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Metropolis Healthcare Ltd - 542650 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Attachments (1)
📄pdf
Download →
7DBAB101_35B4_44B7_9814_E1D3F38469BD_155047.pdf
View document text
Metz Advisory LLP
Mumbai, Maharashtra
To, To, To,
BSE Limited, National Stock Exchange of India Limited, Metropolis Healthcare Limited
Scrip Code: 542650 Symbol: METROPOLIS
Dear Sir/Madam,
Subject: Disclosure pursuant to Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers)
Regulations, 2011
We, Metz Advisory LLP, promoter of Metropolis Healthcare Limited (“Target Company”), wish to inform you that we
have sold 10,50,000 (Ten Lakh Fifty Thousand) Equity Shares of the Target Company (representing 0.51% of
shareholding of the Target Company) through open market sale on August 11, 2026.
Accordingly, enclosed herewith is the requisite disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of
Shares and Takeovers) Regulations, 2011.
Kindly take the same on record.
Thanking you,
Yours faithfully,
For Metz Advisory LLP
(Promoter)
Ameera Shah
Designated Partner
DPIN: 00208095
Place: Mumbai
Date: August 13, 2026
Metz Advisory LLP
Mumbai, Maharashtra
Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and
Takeovers) Regulations, 2011
Name of the Target Company (TC) Metropolis Healthcare Limited
Seller:
Name(s) of the acquirer/ seller and Persons
Metz Advisory LLP (Promoter)
Acting in Concert (PAC) with the acquirer/
seller
Person Acting in Concert (PAC):
Promoters:
Dr. Sushil Shah
Ms. Ameera Shah
Sushil Shah Family Trust
Promoter Group:
Duru Shah Family Trust
Dr. Duru Sushil Shah
Mayur Shah
Whether the acquirer/ seller belongs to
Yes (Promoter Group)
Promoter/ Promoter group
Name(s) of the Stock Exchange(s) where the - BSE Limited and
shares of TC are Listed - National Stock Exchange of India Limited
Number % w.r.t. total share/ % w.r.t. total
Details of the acquisition/ disposal as follows
voting capital diluted share/
wherever applicable voting capital of
(*) the TC (**)
Before the disposal under consideration,
holding of transferor and PACs:
a) Shares carrying voting rights
Seller – 6,27,64,864 Seller – 30.26 % Seller – 30.26 %
#Together with #Together with #Together with
PACs- 10,13,11,984 PACs - 48.85 % PACs - 48.85 %
b) Shares in the nature of encumbrance
Seller – 12,00,000 Seller – 12,00,000 Seller – 12,00,000
(pledge/ lien/ non-disposal
Together with Together with Together with
undertaking/ others)
PACs - 12,00,000 PACs - 0.58 % PACs - 0.58 %
c) Voting rights (VR) otherwise than by
NIL NIL NIL
shares
Nil Nil
36,83,760 NA
7.193
Metz Advisory LLP
Mumbai, Maharashtra
d) Warrants/ convertible securities/ any
NIL NIL NIL
other instrument that entitles the
acquirer to receive shares carrying
voting rights in the TC (specify
holding in each category)
e) Total (a+b+c+d)
Seller – 6,27,64,864 Seller – 30.26 % Seller – 30.26 %
#Together with #Together with #Together with
PACs - 10,13,11,984 PACs - 48.85 % PACs - 48.85 %
Details of acquisition/ sale: 4 8.85 %
4 9.75 %
a) Shares carrying voting rights acquired/ Seller - 10 ,50,000 Seller - 0.51 % Seller - 0.51 %
sold
b) VRs acquired/ sold otherwise than by NIL NIL NIL
shares
c) Warrants/ convertible securities/ any
other instrument that entitles the NIL NIL NIL
acquirer to receive shares carrying
voting rights in the TC (specify
holding in each category) acquired/
sold
NIL NIL NIL
d) Shares encumbered/ invoked/ released
by the acquirer
Seller - 10,50,000 Seller - 0.51 % Seller - 0.51 %
e) Total (a+b+c+/-d)
After the acquisition/ sale, holding of:
Seller – 6,17,14,864 Seller – 29.76 % Seller – 29.76 %
a) Shares carrying voting rights
#Together with #Together with #Together with
PACs – 9,92,11,984^ PACs - 47.84 %^ PACs - 47.84 %^
b) Shares encumbered with the acquirer
Seller – 12,00,000 Seller – 12,00,000 Seller – 12,00,000
Together with Together with Together with
PACs - 12,00,000 PACs - 0.58 % PACs - 0.58 %
c) VRs otherwise than by shares
NIL NIL NIL
Metz Advisory LLP
Mumbai, Maharashtra
d) Warrants/ convertible securities/ any NIL NIL NIL
other instrument that entitles the
acquirer to receive shares carrying
voting rights in the TC (specify
holding in each category) acquired/
sold
e) Total (a+b+c+/-d) Seller – 6,17,14,864 Seller – 29.76 % Seller – 29.76 %
#Together with #Together with #Together with
PACs – 9,92,11,984^ PACs - 47.84 %^ PACs - 47.84 %^
48.35 %
Mode of acquisition/ sale (e.g. open market/
Open Market. 48.35 %
off-market/ public issue/ rights issue/
48.35 %
preferential allotment/ inter-se transfer etc).
Date of acquisition/ sale of shares/ VR or
August 11, 2026
date of receipt of intimation of allotment of
shares, whichever is applicable
Equity share capital/ total voting capital of 20,73,87,568 Equity Shares of face value INR 2/- each aggregating
the TC before the said acquisition/ sale to INR 41,47,75,136/-
Equity share capital/ total voting capital of 20,73,87,568 Equity Shares of face value INR 2/- each aggregating
the TC after the said acquisition/ sale to INR 41,47,75,136/-
Total diluted share/ voting capital of the TC 20,73,87,568 Equity Shares of face value INR 2/- each aggregating
after the said acquisition/ sale to INR 41,47,75,136/-
# Includes 12,00,000 pledged Equity Shares
^ Includes the sale of 10,50,000 equity shares of the Target Company by Duru Shah Family Trust, executed on
August 11, 2026.
(*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the Stock Exchange.
Note: Subsequent to the shareholding pattern filed by the Company with the Stock Exchanges for the quarter ended
June 30, 2026, the Company allotted 36,900 and 18,700 Equity Shares pursuant to Metropolis – Restrictive Stock
Unit Plan, 2020, on July 09, 2026 and August 04, 2026, respectively. Accordingly, the shareholding percentages have
been calculated based on the total number of Equity Shares of the Company outstanding as on the date of the trade.
(**) Diluted share/ voting capital means the total number of shares in the TC assuming full conversion of the
outstanding convertible securities/ warrants into equity shares of the TC.
Signature of the Seller
For Metz Advisory LLP
(Promoter)
Ameera Shah
Designated Partner
DPIN: 00208095
Place: Mumbai
Date: August 13, 2026
******